Organigram Global Inc. (OGI)

NASDAQ: OGI · USD

$0.92

-0.05 (-4.7%)· Recorded snapshot

Market cap	129M
Revenue (ttm)	217.7M
Net income (ttm)	61M
EPS (ttm)	$0.45
Shares out	141M
P/E (trailing)	2.0x
P/E (forward)	16.3x
Volume	1,725,231.374
Beta	1.91

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 217.7M
Net income (ttm): 61M
EPS (ttm): $0.45
P/E (trailing): 2.0x
P/E (forward): 16.3x
Market cap: 129M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/E16.3

P25 13.4P50 20.2P75 35.7

Trailing P/E2

P25 15.4P50 25.8P75 43.5

ROE17.6

P25 -113.8P50 -46.5P75 -0.9

ROIC-1.3

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All OGI indicators

Market & fundamental data

Available fields

225

Groups with data

Currency

CAD

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001620737
Company name	Organigram Global Inc.
Country	Canada
Country code	US
CUSIP number	68617J100
Earnings date	2026-12-15
Earnings time	bmo
Employees	1,120
Employees change	-30
Employees growth	-2.61%
Enterprise value	$194M
Exchange	NASDAQ
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	September
Founded	2013
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
Is SPAC	No
ISIN number	CA68617J1003
Last earnings date	2026-08-11
Last refreshed	2026-11-04
Last stock split date	2023-07-07
Last stock split type	Reverse
Market cap	$129M
Market cap category	Micro-Cap
Next earnings date	2026-12-15
Options	Yes
Price	$0.92
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	OGI
Website	https://www.organigram.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	49.46%
EV/Earnings	3.18x
EV/EBITDA	16.77x
EV/Sales	0.89x
FCF / EV yield	-10.95%
FCF yield	-16.47%
Forward EV/Sales	0.6x
Forward P/E	16.34x
Forward P/S	0.4x
Graham number	5.23156
Graham upside	468.71%
Industry forward P/E	14.04x
Industry P/E	107.82x
P/B ratio	0.33x
P/E ratio	2.02x
P/S ratio	0.59x
Price / tangible book value	2.1x
Price/EBITDA ratio	11.15x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-2.16%
EBITDA margin	5.31%
Gross margin	36.54%
Operating margin	-2.16%
Pretax margin	26.29%
Profit margin	28.02%
Profit per employee	$54,462
Profitable quarters	1
Revenue per employee	$194,387
ROA	-0.6%
ROCE	-0.94%
ROE	17.56%
ROIC	-1.33%
ROIC (5Y)	-14.06%
SBC / revenue	1.18%
Tax / revenue	-1.73%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	821.78%
EPS growth quarters	1
EPS growth years	2
Gross profit growth	49.46%
Gross profit growth (Q)	58.43%
Gross profit growth 3Y	52.96%
Net income growth	1,014.54%
Net income growth quarters	1
Net income growth years	2
Revenue growth	38.14%
Revenue growth (Q)	49.43%
Revenue growth (QoQ)	76.91%
Revenue growth 10Y	77.67%
Revenue growth 3Y	28.47%
Revenue growth 5Y	28.93%
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-810,289
Depreciation and amortization	$16.6M
EBIT	$-4.7M
EBITDA	$11.6M
EPS	$0.45
FCF per share	$-0.15
Financing cash flow	$58.9M
Free cash flow	$-21.2M
Free cash flow minus SBC	$-23.9M
Gross profit	$79.6M
Income taxes	$-3.8M
Investing cash flow	$-91.3M
Net borrowing	$13.6M
Net cash flow	$-17.6M
Net income	$61M
Operating cash flow minus SBC	$-23.1M
Operating income	$-4.7M
Revenue	$217.7M
Stock-based compensation	$2.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.42
Book value per share	$2.42
Debt / EBITDA	1.81
Debt / equity	0.06
Goodwill	$139.5M
Long-term assets	$376.9M
Long-term liabilities	$108.9M
Net cash (debt)	$-14.1M
Net cash / market cap	-10.91%
Net debt / EBITDA	1.22
Net debt / equity	0.04
Piotroski F-Score	3
Property, plant and equipment	$86.8M
Shareholders' equity	$391.9M
Tangible book value	$61.4M
Tangible book value per share	$0.44
Total assets	$577.6M
Total cash	$8.2M
Total debt	$22.3M
Total liabilities	$185.7M
WACC	12.59%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.45
Current assets	$200.7M
Current liabilities	$76.9M
Current ratio	2.61
Inventory turnover	1.35
Net working capital	$117.1M
Quick ratio	0.93
Working capital	$121.7M
Working capital turnover	1.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-21.14%
Dividend yield	0%
Shareholder yield	-21.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-88.43%
10Y return CAGR	-19.4%
10Y total return	-88.43%
150-day SMA	$1.11
1D price change	-4.68%
1M price change	-3.48%
1M total return	-3.48%
1W price change	-2.05%
1W total return	-2.05%
1Y price change	-43.22%
1Y return CAGR	-43.24%
1Y total return	-43.22%
20-day SMA	$0.94
200-day SMA	$1.19
3M price change	-2.07%
3M total return	-2.07%
3Y price change	-17.13%
3Y return CAGR	-6.07%
3Y total return	-17.13%
50-day SMA	$1.04
50-day SMA vs 200-day SMA	50under200
52-week high	$2.24
52-week high date	2025-12-18
52-week low	$0.85
52-week low date	2026-07-16
5Y price change	-89.87%
5Y return CAGR	-36.74%
5Y total return	-89.87%
6M price change	-35.22%
6M total return	-35.22%
After-hours change	3.27%
After-hours close	$0.92
After-hours price	$0.95
All-time high	$33.76
All-time high date	2019-05-21
All-time low	$0.65
All-time low date	2015-09-28
Average true range (ATR)	$0.04
Average volume	346.2K
Beta (5Y)	1.91
Change from 52-week high	-58.93%
Change from 52-week low	7.83%
Change from all-time high	-97.28%
Change from all-time low	41.26%
Change from open	-1.09%
Day's gap	-3.64%
Dollar volume	$1.6M
High price	$0.97
Low price	$0.86
Monthly RSI	37.51
Open price	$0.93
Position in 52-week range	51.93%
Premarket change	3.26%
Premarket close	$0.92
Premarket price	$0.95
Premarket volume	11.8K
Previous close	$0.97
Price vs 150-day SMA	-17.2%
Price vs 20-day SMA	-2.04%
Price vs 200-day SMA	-22.96%
Price vs 50-day SMA	-11.29%
Relative volume	4.98
RSI	39.96
Sharpe ratio	-0.78
Sharpe ratio (3Y)	0.22
Sharpe ratio (5Y)	-0.4
Sortino ratio	-1.05
Sortino ratio (3Y)	0.45
Sortino ratio (5Y)	-0.51
Volume	1.7M
Weekly RSI	37.03
YTD price change	-45.24%
YTD total return	-45.24%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97.3M
Float percentage	69.03%
Shares change (QoQ)	3.77%
Shares change (YoY)	21.14%
Shares held by insiders	1.02%
Shares held by institutions	3.85%
Shares outstanding	141M
Short % of float	4.95%
Short % of shares	3.42%
Short ratio	9.9 days

Deeper analysis on OGI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OGI report

Is a complete OGI research report available?

No complete published report is available for Organigram Global Inc. (OGI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Organigram Global Inc. (OGI)

Price

Financial snapshot

Fair-value bridge

Latest news · OGI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OGI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OGI

Frequently asked questions